{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:16Z","timestamp":1793320756859,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01807-x","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:32:04Z","timestamp":1772616724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of insulin-like growth factor-1\/2 and related signaling in parkinson\u2019s disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Emad","family":"Manni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabat J.","family":"Al-Maiahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-8897","authenticated-orcid":false,"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-4666","authenticated-orcid":false,"given":"Mustafa M.","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-7236","authenticated-orcid":false,"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-874X","authenticated-orcid":false,"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa M","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/ijms23010398","volume":"23","author":"F Agostini","year":"2022","unstructured":"Agostini F, Masato A, Bubacco L, Bisaglia M (2022) Metformin repurposing for Parkinson disease therapy: opportunities and challenges. Int J Mol Sci 23:398. https:\/\/doi.org\/10.3390\/ijms23010398","journal-title":"Int J Mol Sci"},{"key":"1807_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-023-02656-6","volume":"397","author":"HM Al-kuraishy","year":"2024","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Selim HM et al (2024a) Does vitamin D protect or treat parkinson\u2019s disease? A narrative review. Naunyn Schmiedebergs Arch Pharmacol 397:33\u201340. https:\/\/doi.org\/10.1007\/s00210-023-02656-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1807_CR3","doi-asserted-by":"publisher","unstructured":"Al-kuraishy HM, Al-Hamash SM, Jabir MS et al (2024b) The classical and non-classical axes of renin-angiotensin system in Parkinson disease: the bright and dark side of the Moon. Ageing Res Rev 94. https:\/\/doi.org\/10.1016\/j.arr.2024.102200","DOI":"10.1016\/j.arr.2024.102200"},{"key":"1807_CR4","doi-asserted-by":"publisher","unstructured":"Al-kuraishy HM, Sulaiman GM, Saad HM et al (2025) The effect of Metformin on astrocytes in parkinson\u2019s disease: challenges and opportunities. Mol Neurobiol 1\u20135. https:\/\/doi.org\/10.1007\/s12035-025-05098-8","DOI":"10.1007\/s12035-025-05098-8"},{"key":"1807_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","volume":"46","author":"CM Alberini","year":"2023","unstructured":"Alberini CM (2023) IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases. Trends Neurosci 46:488\u2013502. https:\/\/doi.org\/10.1016\/j.tins.2023.03.007","journal-title":"Trends Neurosci"},{"key":"1807_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124471","volume":"21","author":"H Albert-Gasc\u00f3","year":"2020","unstructured":"Albert-Gasc\u00f3 H, Ros-Bernal F, Castillo-G\u00f3mez E, Olucha-Bordonau FE (2020) Map\/erk signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes. Int J Mol Sci 21:1\u201329. https:\/\/doi.org\/10.3390\/ijms21124471","journal-title":"Int J Mol Sci"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s40001-024-01779-7","volume":"29","author":"B Alharbi","year":"2024","unstructured":"Alharbi B, Al-kuraishy HM, Al-Gareeb AI et al (2024) Role of GABA pathway in motor and non-motor symptoms in parkinson\u2019s disease: a bidirectional circuit. Eur J Med Res 29:205. https:\/\/doi.org\/10.1186\/s40001-024-01779-7","journal-title":"Eur J Med Res"},{"key":"1807_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2018.00117","volume":"9","author":"JB Allard","year":"2018","unstructured":"Allard JB, Duan C (2018) IGF-binding proteins: why do they exist and why are there so many? Front Endocrinol (Lausanne) 9:117. https:\/\/doi.org\/10.3389\/fendo.2018.00117","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","volume":"479","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-kuraishy HM, Al-Gareeb AI et al (2024) Metformin role in parkinson\u2019s disease: a double-sword effect. Mol Cell Biochem 479:975\u2013991. https:\/\/doi.org\/10.1007\/s11010-023-04771-7","journal-title":"Mol Cell Biochem"},{"key":"1807_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177830","author":"SM Alshahrani","year":"2025","unstructured":"Alshahrani SM, Al-kuraishy HM, Al-Gareeb AI et al (2025a) LRP1 at the crossroads of parkinson\u2019s and alzheimer\u2019s: divergent roles in \u03b1-synuclein and amyloid pathology. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177830. 1002:","journal-title":"Eur J Pharmacol"},{"key":"1807_CR11","doi-asserted-by":"publisher","first-page":"157010","DOI":"10.1016\/J.CYTO.2025.157010","volume":"194","author":"SM Alshahrani","year":"2025","unstructured":"Alshahrani SM, Al-kuraishy HM, Al-Gareeb AI et al (2025b) Dysregulation of the leukotriene pathway in parkinson\u2019s disease: the potential role of Montelukast. Cytokine 194:157010. https:\/\/doi.org\/10.1016\/J.CYTO.2025.157010","journal-title":"Cytokine"},{"key":"1807_CR12","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1212\/WNL.98.18_SUPPLEMENT.2832","volume":"98","author":"MM Alwerdani","year":"2022","unstructured":"Alwerdani MM, El-Sayed AS, Hanbal A et al (2022) Serum Insulin-like growth Factor-1 as a biomarker for parkinson\u2019s disease: A systematic review and meta-analysis. (P1-1.Virtual). Neurology 98:2832. https:\/\/doi.org\/10.1212\/WNL.98.18_SUPPLEMENT.2832","journal-title":"Neurology"},{"key":"1807_CR13","doi-asserted-by":"publisher","first-page":"e70076","DOI":"10.1111\/cns.70076","volume":"30","author":"J An","year":"2024","unstructured":"An J, Wen L, Yu H et al (2024) Insulin-Like growth factor binding protein 2 drives neurodegeneration in parkinson\u2019s disease: insights from in vivo and in vitro studies. CNS Neurosci Ther 30:e70076. https:\/\/doi.org\/10.1111\/cns.70076","journal-title":"CNS Neurosci Ther"},{"key":"1807_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.33003\/fjs-2025-0902-3219","volume":"9","author":"EF Antenyi","year":"2025","unstructured":"Antenyi EF, Momoh OM, Tor NE, POLYMORPHISMS WITHIN THE EXON 3 REGION OF IGF1 GENE OF TWO SAVANNAH MUTURU POPULATIONS IN NIGERIA USING RFLP MARKER (2025) FUDMA J Sci 9:231\u2013236. https:\/\/doi.org\/10.33003\/fjs-2025-0902-3219","journal-title":"FUDMA J Sci"},{"key":"1807_CR15","doi-asserted-by":"publisher","first-page":"174800","DOI":"10.1016\/j.ejphar.2022.174800","volume":"919","author":"BD Arbo","year":"2022","unstructured":"Arbo BD, Schimith LE, Goulart dos Santos M, Hort MA (2022) Repositioning and development of new treatments for neurodegenerative diseases: focus on neuroinflammation. Eur J Pharmacol 919:174800. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174800","journal-title":"Eur J Pharmacol"},{"key":"1807_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41420-023-01734-1","volume":"9","author":"J Arcos","year":"2023","unstructured":"Arcos J, Grunenwald F, Sepulveda D et al (2023) IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in parkinson\u2019s disease models. Cell Death Discov 9:438. https:\/\/doi.org\/10.1038\/s41420-023-01734-1","journal-title":"Cell Death Discov"},{"key":"1807_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13578-023-00966-z","volume":"13","author":"A Arjunan","year":"2023","unstructured":"Arjunan A, Sah DK, Woo M, Song J (2023) Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell Biosci 13:16. https:\/\/doi.org\/10.1186\/s13578-023-00966-z","journal-title":"Cell Biosci"},{"key":"1807_CR18","doi-asserted-by":"publisher","first-page":"176851","DOI":"10.1016\/j.ejphar.2024.176851","volume":"980","author":"GA Badawi","year":"2024","unstructured":"Badawi GA, Shokr MM, Elshazly SM et al (2024) Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats. Eur J Pharmacol 980:176851. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176851","journal-title":"Eur J Pharmacol"},{"key":"1807_CR19","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11:1164\u20131178. https:\/\/doi.org\/10.5114\/aoms.2015.56342","journal-title":"Arch Med Sci"},{"key":"1807_CR20","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1212\/WNL.0b013e3182752eef","volume":"79","author":"EE Benarroch","year":"2012","unstructured":"Benarroch EE (2012) Insulin-like growth factors in the brain and their potential clinical implications. Neurology 79:2148\u20132153. https:\/\/doi.org\/10.1212\/WNL.0b013e3182752eef","journal-title":"Neurology"},{"key":"1807_CR21","doi-asserted-by":"publisher","first-page":"e0150552","DOI":"10.1371\/journal.pone.0150552","volume":"11","author":"FP Bernhard","year":"2016","unstructured":"Bernhard FP, Heinzel S, Binder G et al (2016) Insulin-like growth factor 1 (IGF-1) in parkinson\u2019s disease: potential as trait-, progression- and prediction marker and confounding factors. PLoS ONE 11:e0150552. https:\/\/doi.org\/10.1371\/journal.pone.0150552","journal-title":"PLoS ONE"},{"key":"1807_CR22","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.str.2020.08.002","volume":"28","author":"AJ Bochel","year":"2020","unstructured":"Bochel AJ, Williams C, McCoy AJ et al (2020) Structure of the human Cation-Independent mannose 6-Phosphate\/IGF2 receptor domains 7\u201311 uncovers the mannose 6-Phosphate binding site of domain 9. Structure 28:1300\u20131312e5. https:\/\/doi.org\/10.1016\/j.str.2020.08.002","journal-title":"Structure"},{"key":"1807_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/FNINS.2018.00476\/FULL","volume":"12","author":"LW Bonham","year":"2018","unstructured":"Bonham LW, Geier EG, Steele NZR et al (2018) Insulin-like growth factor binding protein 2 is associated with biomarkers of alzheimer\u2019s disease pathology and shows differential expression in Transgenic mice. Front Neurosci 12:476. https:\/\/doi.org\/10.3389\/FNINS.2018.00476\/FULL","journal-title":"Front Neurosci"},{"key":"1807_CR24","doi-asserted-by":"crossref","unstructured":"Brismar K, Hilding A, Ansurudeen I et al (2023) Adiponectin, IGFBP-1 and \u2013\u20092 are independent predictors in forecasting prediabetes and type 2 diabetes","DOI":"10.3389\/fendo.2022.1092307"},{"key":"1807_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"1807_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12902-024-01622-4","volume":"24","author":"S Caprio","year":"2024","unstructured":"Caprio S, Pilli T, Cantara S et al (2024) Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight. BMC Endocr Disord 24:94. https:\/\/doi.org\/10.1186\/s12902-024-01622-4","journal-title":"BMC Endocr Disord"},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/S12967-020-02223-0","volume":"181 18","author":"I Castilla-Cort\u00e1zar","year":"2020","unstructured":"Castilla-Cort\u00e1zar I, Aguirre GA, Femat-Rold\u00e1n G et al (2020) Is insulin-like growth factor-1 involved in parkinson\u2019s disease development? J Transl Med 2020 181 18:70\u2013. https:\/\/doi.org\/10.1186\/S12967-020-02223-0","journal-title":"J Transl Med 2020"},{"key":"1807_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fncel.2019.00298","volume":"13","author":"W Chen","year":"2019","unstructured":"Chen W, He B, Tong W et al (2019) Astrocytic insulin-like growth factor-1 protects neurons against excitotoxicity. Front Cell Neurosci 13:298. https:\/\/doi.org\/10.3389\/fncel.2019.00298","journal-title":"Front Cell Neurosci"},{"key":"1807_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/S12031-008-9041-2","volume":"351 35","author":"D Chesik","year":"2008","unstructured":"Chesik D, De Keyser J, Wilczak N (2008) Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci 2008 351 35:81\u201390. https:\/\/doi.org\/10.1007\/S12031-008-9041-2","journal-title":"J Mol Neurosci 2008"},{"key":"1807_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000325028","volume":"19","author":"JY Chung","year":"2011","unstructured":"Chung JY, Lee SJ, Lee SH et al (2011) Direct interaction of \u03b1-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease. Neurosignals 19:86\u201396. https:\/\/doi.org\/10.1159\/000325028","journal-title":"Neurosignals"},{"key":"1807_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"key":"1807_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1210\/endrev\/bnae029","volume":"46","author":"CA Conover","year":"2025","unstructured":"Conover CA, Oxvig C (2025) The IGF system and aging. Endocr Rev 46:214\u2013223. https:\/\/doi.org\/10.1210\/endrev\/bnae029","journal-title":"Endocr Rev"},{"key":"1807_CR33","doi-asserted-by":"publisher","first-page":"105935","DOI":"10.1016\/J.PARKRELDIS.2023.105935","volume":"119","author":"J Dulski","year":"2024","unstructured":"Dulski J, Uitti RJ, Beasley A et al (2024) Genetics of parkinson\u2019s disease heterogeneity: A genome-wide association study of clinical subtypes. Parkinsonism Relat Disord 119:105935. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2023.105935","journal-title":"Parkinsonism Relat Disord"},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","volume":"325","author":"AH Dyer","year":"2016","unstructured":"Dyer AH, Vahdatpour C, Sanfeliu A, Tropea D (2016) The role of Insulin-Like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience 325:89\u201399. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.03.056","journal-title":"Neuroscience"},{"key":"1807_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","volume":"209","author":"AD Ebert","year":"2008","unstructured":"Ebert AD, Beres AJ, Barber AE, Svendsen CN (2008) Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of parkinson\u2019s disease. Exp Neurol 209:213\u2013223. https:\/\/doi.org\/10.1016\/j.expneurol.2007.09.022","journal-title":"Exp Neurol"},{"key":"1807_CR36","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1002\/alz.13678","volume":"20","author":"P Edison","year":"2024","unstructured":"Edison P (2024) Astroglial activation: current concepts and future directions. Alzheimer\u2019s Dement 20:3034\u20133053. https:\/\/doi.org\/10.1002\/alz.13678","journal-title":"Alzheimer\u2019s Dement"},{"key":"1807_CR37","doi-asserted-by":"publisher","first-page":"26150","DOI":"10.1074\/jbc.M703276200","volume":"282","author":"HM El-Shewy","year":"2007","unstructured":"El-Shewy HM, Lee MH, Obeid LM et al (2007) The insulin-like growth factor type 1 and insulin-like growth factor type 2\/mannose-6-phosphate receptors independently regulate ERK1\/2 activity in HEK293 cells. J Biol Chem 282:26150\u201326157. https:\/\/doi.org\/10.1074\/jbc.M703276200","journal-title":"J Biol Chem"},{"key":"1807_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/cjn.2015.244","volume":"43","author":"LW Ferguson","year":"2016","unstructured":"Ferguson LW, Rajput AH, Rajput A (2016) Early-onset vs. Late-onset Parkinson?s disease: A Clinical-pathological study. Can J Neurol Sci 43:113\u2013119","journal-title":"Can J Neurol Sci"},{"key":"1807_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2478\/enr-2023-0009","volume":"57","author":"E Fraenkel","year":"2023","unstructured":"Fraenkel E, Lazurova I (2023) IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients. Endocr Regul 57:69\u201379. https:\/\/doi.org\/10.2478\/enr-2023-0009","journal-title":"Endocr Regul"},{"key":"1807_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/archneurol.2011.129","volume":"68","author":"J Godau","year":"2011","unstructured":"Godau J, Knauel K, Weber K et al (2011) Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease. Arch Neurol 68:925\u2013931. https:\/\/doi.org\/10.1001\/archneurol.2011.129","journal-title":"Arch Neurol"},{"key":"1807_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neuint.2007.04.030","volume":"51","author":"DC G\u00f3recki","year":"2007","unstructured":"G\u00f3recki DC, Beresewicz M, Zab\u0142ocka B (2007) Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1. Neurochem Int 51:451\u2013458. https:\/\/doi.org\/10.1016\/j.neuint.2007.04.030","journal-title":"Neurochem Int"},{"key":"1807_CR42","doi-asserted-by":"publisher","unstructured":"Grunenwald F, Huerta TJ, Sepulveda D et al (2025) IGF2-Reprogrammed macrophages ameliorate the inflammatory response and protect against the neuroinflammatory process in parkinson\u2019s disease models. https:\/\/doi.org\/10.1111\/acel.70020. Aging Cell e70020:","DOI":"10.1111\/acel.70020"},{"key":"1807_CR43","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-024-07835-8","volume":"46","author":"L Gu","year":"2024","unstructured":"Gu L, Zhang P, Zuo W et al (2024) Association between serum IGF\u20131 levels and non-motor symptoms in parkinson\u2019s disease. Neurol Sci 46:1201\u20131206. https:\/\/doi.org\/10.1007\/s10072-024-07835-8","journal-title":"Neurol Sci"},{"key":"1807_CR44","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/J.1476-5381.2009.00256","volume":"157","author":"J Guan","year":"2009","unstructured":"Guan J, Gluckman PD (2009) IGF-1 derived small neuropeptides and analogues: A novel strategy for the development of pharmaceuticals for neurological conditions. Br J Pharmacol 157:881\u2013891. https:\/\/doi.org\/10.1111\/J.1476-5381.2009.00256.X;WEBSITE:WEBSITE:BPSPUBS;ISSUE:ISSUE:DOI","journal-title":"Br J Pharmacol"},{"key":"1807_CR45","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/molecules28031021","volume":"28","author":"J Guan","year":"2023","unstructured":"Guan J, Li F, Kang D et al (2023) Cyclic Glycine-Proline (cGP) normalises Insulin-Like growth Factor-1 (IGF-1) function: clinical significance in the ageing brain and in Age-Related neurological conditions. Molecules 28:1021. https:\/\/doi.org\/10.3390\/molecules28031021","journal-title":"Molecules"},{"key":"1807_CR46","doi-asserted-by":"publisher","first-page":"T171","DOI":"10.1530\/JME-18-0093","volume":"61","author":"S Gubbi","year":"2018","unstructured":"Gubbi S, Quipildor GF, Barzilai N et al (2018) IGF-1: the Jekyll & Hyde of the aging brain. J Mol Endocrinol 61:T171. https:\/\/doi.org\/10.1530\/JME-18-0093","journal-title":"J Mol Endocrinol"},{"key":"1807_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/j.jin2311203","volume":"23","author":"O Harackiewicz","year":"2024","unstructured":"Harackiewicz O, Grembecka B (2024) The role of microglia and astrocytes in the pathomechanism of neuroinflammation in parkinson\u2019s Disease-Focus on Alpha-Synuclein. J Integr Neurosci 23:203. https:\/\/doi.org\/10.31083\/j.jin2311203","journal-title":"J Integr Neurosci"},{"key":"1807_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1095\/biolreprod.110.088195","volume":"84","author":"LK Harris","year":"2011","unstructured":"Harris LK, Crocker IP, Baker PN et al (2011) IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor. Biol Reprod 84:440\u2013446. https:\/\/doi.org\/10.1095\/biolreprod.110.088195","journal-title":"Biol Reprod"},{"key":"1807_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molmet.2018.10.008","volume":"19","author":"NJ Haywood","year":"2019","unstructured":"Haywood NJ, Slater TA, Matthews CJ, Wheatcroft SB (2019) The insulin like growth factor and binding protein family: novel therapeutic targets in obesity & diabetes. Mol Metab 19:86\u201396. https:\/\/doi.org\/10.1016\/j.molmet.2018.10.008","journal-title":"Mol Metab"},{"key":"1807_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-031-89525-8_4","volume":"1477","author":"S Ho","year":"2025","unstructured":"Ho S, Narayan SI, Tropea D (2025) Insulin- like growth Factor-1 as Brain-Body connector. Adv Exp Med Biol 1477:83\u2013104. https:\/\/doi.org\/10.1007\/978-3-031-89525-8_4","journal-title":"Adv Exp Med Biol"},{"key":"1807_CR51","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/01.JCP.0000239791.91330.48","volume":"26","author":"OD Howes","year":"2006","unstructured":"Howes OD, Smith S, Gaughran FP et al (2006) The relationship between prolactin levels and glucose homeostasis in antipsychotic treated schizophrenic patients. J Clin Psychopharmacol 26:629. https:\/\/doi.org\/10.1097\/01.JCP.0000239791.91330.48","journal-title":"J Clin Psychopharmacol"},{"key":"1807_CR52","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R et al (2023) Microglia mediated neuroinflammation in parkinson\u2019s disease. Cells 12:1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"1807_CR53","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/v13081488","volume":"13","author":"A J\u00f3zefiak","year":"2021","unstructured":"J\u00f3zefiak A, Larska M, Pomorska-M\u00f3l M, Ruszkowski JJ (2021) The igf-1 signaling pathway in viral infections. Viruses 13:1488. https:\/\/doi.org\/10.3390\/v13081488","journal-title":"Viruses"},{"key":"1807_CR54","doi-asserted-by":"publisher","first-page":"105654","DOI":"10.1016\/j.nbd.2022.105654","volume":"166","author":"A Kasen","year":"2022","unstructured":"Kasen A, Houck C, Burmeister AR et al (2022) Upregulation of \u03b1-synuclein following immune activation: possible trigger of parkinson\u2019s disease. Neurobiol Dis 166:105654. https:\/\/doi.org\/10.1016\/j.nbd.2022.105654","journal-title":"Neurobiol Dis"},{"key":"1807_CR55","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1038\/s41388-022-02353-3","volume":"41","author":"A Kerr","year":"2022","unstructured":"Kerr A, Baxter RC (2022) Noncoding RNA actions through IGFs and IGF binding proteins in cancer. Oncogene 41:3385\u20133393. https:\/\/doi.org\/10.1038\/s41388-022-02353-3","journal-title":"Oncogene"},{"key":"1807_CR56","doi-asserted-by":"publisher","first-page":"108047","DOI":"10.1016\/j.jbc.2024.108047","volume":"301","author":"MZ Khan","year":"2025","unstructured":"Khan MZ, Zugaza JL, Torres Aleman I (2025) The signaling landscape of insulin-like growth factor 1. J Biol Chem 301:108047. https:\/\/doi.org\/10.1016\/j.jbc.2024.108047","journal-title":"J Biol Chem"},{"key":"1807_CR57","doi-asserted-by":"publisher","first-page":"177419","DOI":"10.1016\/j.ejphar.2025.177419","volume":"995","author":"MM Khowdiary","year":"2025","unstructured":"Khowdiary MM, Al-kuraishy HM, Al-Gareeb AI et al (2025) Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet. Eur J Pharmacol 995:177419. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177419","journal-title":"Eur J Pharmacol"},{"key":"1807_CR58","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00213-012-2841-7","volume":"225","author":"Y Kita","year":"2013","unstructured":"Kita Y, Ago Y, Takano E et al (2013) Galantamine increases hippocampal insulin-like growth factor 2 expression via \u03b17 nicotinic acetylcholine receptors in mice. Psychopharmacology 225:543\u2013551. https:\/\/doi.org\/10.1007\/s00213-012-2841-7","journal-title":"Psychopharmacology"},{"key":"1807_CR59","doi-asserted-by":"publisher","first-page":"737","DOI":"10.26402\/jpp.2018.5.08","volume":"69","author":"M Kujawska-Luczak","year":"2018","unstructured":"Kujawska-Luczak M, Szulinska M, Skrypnik D et al (2018) The influence of orlistat, Metformin and diet on serum levels of insulin-like growth factor-1 in obese women with and without insulin resistance. J Physiol Pharmacol 69:737\u2013745. https:\/\/doi.org\/10.26402\/jpp.2018.5.08","journal-title":"J Physiol Pharmacol"},{"key":"1807_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.20517\/2347-8659.2020.58","volume":"8","author":"TK Lee","year":"2022","unstructured":"Lee TK, Yankee EL (2022) A review on parkinson\u2019s disease treatment. Neuroimmunol Neuroinflammation 8:222. https:\/\/doi.org\/10.20517\/2347-8659.2020.58","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"1807_CR61","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.molmet.2021","volume":"52","author":"D LeRoith","year":"2021","unstructured":"LeRoith D, Holly JM, Forbes BE (2021a) Insulin-like growth factors: Ligands, binding proteins, and receptors. Mol Metab 52:101245. https:\/\/doi.org\/10.1016\/j.molmet.2021","journal-title":"Mol Metab"},{"key":"1807_CR62","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.molmet.2021.101245","volume":"52","author":"D LeRoith","year":"2021","unstructured":"LeRoith D, Holly JMP, Forbes BE (2021b) Insulin-like growth factors: Ligands, binding proteins, and receptors. Mol Metab 52:101245. https:\/\/doi.org\/10.1016\/j.molmet.2021.101245","journal-title":"Mol Metab"},{"key":"1807_CR63","doi-asserted-by":"publisher","first-page":"612476","DOI":"10.3389\/fcell.2021.612476","volume":"9","author":"W Li","year":"2021","unstructured":"Li W, Fu YH, Halliday GM, Sue CM (2021) PARK genes link mitochondrial dysfunction and Alpha-Synuclein pathology in sporadic parkinson\u2019s disease. Front Cell Dev Biol 9:612476. https:\/\/doi.org\/10.3389\/fcell.2021.612476","journal-title":"Front Cell Dev Biol"},{"key":"1807_CR64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/bpl-180073","volume":"4","author":"T-W Lin","year":"2018","unstructured":"Lin T-W, Tsai S-F, Kuo Y-M (2018) Physical exercise enhances neuroplasticity and delays alzheimer\u2019s disease. Brain Plast 4:95\u2013110. https:\/\/doi.org\/10.3233\/bpl-180073","journal-title":"Brain Plast"},{"key":"1807_CR65","doi-asserted-by":"publisher","first-page":"102510","DOI":"10.1016\/j.jaut.2020.102510","volume":"113","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang J, Luo S et al (2020) The roles of PPAR\u03b3 and its agonists in autoimmune diseases: A comprehensive review. J Autoimmun 113:102510. https:\/\/doi.org\/10.1016\/j.jaut.2020.102510","journal-title":"J Autoimmun"},{"key":"1807_CR66","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/J.TIPS.2010.09.005","volume":"31","author":"DJ Loane","year":"2010","unstructured":"Loane DJ, Faden AI (2010) Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 31:596. https:\/\/doi.org\/10.1016\/J.TIPS.2010.09.005","journal-title":"Trends Pharmacol Sci"},{"key":"1807_CR67","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.7150\/ijbs.84353","volume":"19","author":"L Ma","year":"2023","unstructured":"Ma L, Zhao W, Huang S et al (2023) IGF\/IGF-1R signal pathway in pain: a promising therapeutic target. Int J Biol Sci 19:3472\u20133482. https:\/\/doi.org\/10.7150\/ijbs.84353","journal-title":"Int J Biol Sci"},{"key":"1807_CR68","doi-asserted-by":"publisher","first-page":"736104","DOI":"10.1155\/2015\/736104","volume":"2015","author":"A Mangiola","year":"2015","unstructured":"Mangiola A, Vigo V, Anile C et al (2015) Role and importance of IGF-1 in traumatic brain injuries. Biomed Res Int 2015:736104. https:\/\/doi.org\/10.1155\/2015\/736104","journal-title":"Biomed Res Int"},{"key":"1807_CR69","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.redox.2021.102095","volume":"46","author":"E Mart\u00edn-Monta\u00f1ez","year":"2021","unstructured":"Mart\u00edn-Monta\u00f1ez E, Valverde N, de Ladr\u00f3n D et al (2021) Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of parkinson\u2019s disease. Redox Biol 46:102095. https:\/\/doi.org\/10.1016\/j.redox.2021.102095","journal-title":"Redox Biol"},{"key":"1807_CR70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jocn.2009.08.013","volume":"17","author":"F Mashayekhi","year":"2010","unstructured":"Mashayekhi F, Mirzajani E, Naji M, Azari M (2010) Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with parkinson\u2019s disease. J Clin Neurosci 17:623\u2013627. https:\/\/doi.org\/10.1016\/j.jocn.2009.08.013","journal-title":"J Clin Neurosci"},{"key":"1807_CR71","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/S00726-011-1210-X","volume":"43","author":"A Minelli","year":"2012","unstructured":"Minelli A, Conte C, Cacciatore I et al (2012) Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a parkinson\u2019s animal model. Amino Acids 43:1359\u20131367. https:\/\/doi.org\/10.1007\/S00726-011-1210-X","journal-title":"Amino Acids"},{"key":"1807_CR72","doi-asserted-by":"publisher","first-page":"436553","DOI":"10.3389\/FNINS.2019.00007\/BIBTEX","volume":"13","author":"M Mohamadpour","year":"2019","unstructured":"Mohamadpour M, Whitney K, Bergold PJ (2019) The importance of therapeutic time window in the treatment of traumatic brain injury. Front Neurosci 13:436553. https:\/\/doi.org\/10.3389\/FNINS.2019.00007\/BIBTEX","journal-title":"Front Neurosci"},{"key":"1807_CR73","doi-asserted-by":"publisher","first-page":"e1259709","DOI":"10.1080\/23262133.2016.1259709","volume":"4","author":"GR Morel","year":"2017","unstructured":"Morel GR, Le\u00f3n ML, Uriarte M et al (2017) Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging. Neurogenesis 4:e1259709. https:\/\/doi.org\/10.1080\/23262133.2016.1259709","journal-title":"Neurogenesis"},{"key":"1807_CR74","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.beem.2010.08.005","volume":"25","author":"I Netchine","year":"2011","unstructured":"Netchine I, Azzi S, Le Bouc Y, Savage MO (2011) IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development. Best Pract Res Clin Endocrinol Metab 25:181\u2013190. https:\/\/doi.org\/10.1016\/j.beem.2010.08.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1807_CR75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jphs.2024.07.008","volume":"156","author":"S Nozaki","year":"2024","unstructured":"Nozaki S, Hijioka M, Wen X et al (2024) Galantamine suppresses \u03b1-synuclein aggregation by inducing autophagy via the activation of \u03b17 nicotinic acetylcholine receptors. J Pharmacol Sci 156:102\u2013114. https:\/\/doi.org\/10.1016\/j.jphs.2024.07.008","journal-title":"J Pharmacol Sci"},{"key":"1807_CR76","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Cidlowski JA (2013) The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 132:1033\u20131044. https:\/\/doi.org\/10.1016\/j.jaci.2013.09.007","journal-title":"J Allergy Clin Immunol"},{"key":"1807_CR77","doi-asserted-by":"publisher","first-page":"E96","DOI":"10.1210\/clinem\/dgad491","volume":"109","author":"MC Okawa","year":"2024","unstructured":"Okawa MC, Tuska RM, Lightbourne M et al (2024) Insulin signaling through the insulin receptor increases linear growth through effects on bone and the GH\u2013IGF-1 axis. J Clin Endocrinol Metab 109:E96\u2013E106. https:\/\/doi.org\/10.1210\/clinem\/dgad491","journal-title":"J Clin Endocrinol Metab"},{"key":"1807_CR78","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1073\/pnas.1806820116","volume":"116","author":"A Prister\u00e0","year":"2019","unstructured":"Prister\u00e0 A, Blomeley C, Lopes E et al (2019) Dopamine neuron-derived IGF-1 controls dopamine neuron firing, skill learning, and exploration. Proc Natl Acad Sci U S A 116:3817\u20133826. https:\/\/doi.org\/10.1073\/pnas.1806820116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1807_CR79","doi-asserted-by":"publisher","unstructured":"Qi C, Luo L, Da, Feng I, Ma S (2022) Molecular mechanisms of synaptogenesis. Front Synaptic Neurosci 14. https:\/\/doi.org\/10.3389\/fnsyn.2022.939793","DOI":"10.3389\/fnsyn.2022.939793"},{"key":"1807_CR80","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/CELLS14141064","volume":"14","author":"S Reed","year":"2025","unstructured":"Reed S, Taka E, Darling-Reed S, Soliman KFA (2025) Neuroprotective effects of Metformin through the modulation of neuroinflammation and oxidative stress. Cells 14:1064. https:\/\/doi.org\/10.3390\/CELLS14141064","journal-title":"Cells"},{"key":"1807_CR81","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.3390\/nu15163585","volume":"15","author":"VA Ruiz-Pozo","year":"2023","unstructured":"Ruiz-Pozo VA, Tamayo-Trujillo R, Cadena-Ullauri S et al (2023) The molecular mechanisms of the relationship between insulin resistance and parkinson\u2019s disease pathogenesis. Nutrients 15:3585. https:\/\/doi.org\/10.3390\/nu15163585","journal-title":"Nutrients"},{"key":"1807_CR82","doi-asserted-by":"publisher","unstructured":"Sep\u00falveda D, Grunenwald F, Vidal A et al (2022) Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in parkinson\u2019s disease. Sci Rep 12(2038). https:\/\/doi.org\/10.1038\/s41598-022-05941-1","DOI":"10.1038\/s41598-022-05941-1"},{"key":"1807_CR83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1389203724666221208145549","volume":"24","author":"Y Sha","year":"2022","unstructured":"Sha Y, Chen L, Xu C et al (2022) The roles of IGF-1 and MGF on nerve regeneration under Hypoxia- Ischemia, Inflammation, oxidative Stress, and physical trauma. Curr Protein Pept Sci 24:143\u2013155. https:\/\/doi.org\/10.2174\/1389203724666221208145549","journal-title":"Curr Protein Pept Sci"},{"key":"1807_CR86","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1016\/J.JCYT.2020.04.057","volume":"22","author":"Y Shi","year":"2020","unstructured":"Shi Y (2020) IGF-2 from low oxygen conditioned mesenchymal stem cells preprograms macrophages for oxidative Phosphorylation-Dependent Anti-inflammatory properties. Cytotherapy 22:S195. https:\/\/doi.org\/10.1016\/J.JCYT.2020.04.057","journal-title":"Cytotherapy"},{"key":"1807_CR85","doi-asserted-by":"publisher","unstructured":"Shi X, Zheng J, Ma J et al (2022) Insulin-like growth factor in parkinson\u2019s disease is related to nonmotor symptoms and the volume of specific brain areas. Neurosci Lett 783. https:\/\/doi.org\/10.1016\/j.neulet.2022.136735","DOI":"10.1016\/j.neulet.2022.136735"},{"key":"1807_CR84","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10072-022-06490-1","volume":"44","author":"X Shi","year":"2023","unstructured":"Shi X, Zheng J, Ma J et al (2023) Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in parkinson\u2019s disease patients. Neurol Sci 44:881\u2013887. https:\/\/doi.org\/10.1007\/s10072-022-06490-1","journal-title":"Neurol Sci"},{"key":"1807_CR87","doi-asserted-by":"publisher","unstructured":"Shokr MM (2025a) Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders. Metab Brain Dis 2025 408 40:326-. https:\/\/doi.org\/10.1007\/S11011-025-01739-Y","DOI":"10.1007\/S11011-025-01739-Y"},{"key":"1807_CR88","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1007\/S10787-025-01955-Z","volume":"3310 33","author":"MM Shokr","year":"2025","unstructured":"Shokr MM (2025b) Beyond the blood\u2013brain barrier: unraveling T cell subsets in CNS immunity and disease. Inflammopharmacology 2025 3310 33:5799\u20135818. https:\/\/doi.org\/10.1007\/S10787-025-01955-Z","journal-title":"Inflammopharmacology 2025"},{"key":"1807_CR89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/acsptsci.4c00564","volume":"8","author":"MM Shokr","year":"2025","unstructured":"Shokr MM, Badawi GA, Elshazly SM et al (2025) Sigma 1 receptor and its pivotal role in neurological disorders. ACS Pharmacol Transl Sci 8:47\u201365. https:\/\/doi.org\/10.1021\/acsptsci.4c00564","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1807_CR90","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1021\/ACSCHEMNEURO.2C00675","volume":"14","author":"SC Silva-Reis","year":"2023","unstructured":"Silva-Reis SC, Sampaio-Dias IE, Costa VM et al (2023) Concise overview of glypromate neuropeptide research: from chemistry to Pharmacological applications in neurosciences. ACS Chem Neurosci 14:554\u2013572. https:\/\/doi.org\/10.1021\/ACSCHEMNEURO.2C00675","journal-title":"ACS Chem Neurosci"},{"key":"1807_CR91","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.1210\/clinem\/dgaa792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"Stanley TL, Fourman LT, Zheng I et al (2021) Relationship of IGF-1 and IGF-Binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 106:E520\u2013E533. https:\/\/doi.org\/10.1210\/clinem\/dgaa792","journal-title":"J Clin Endocrinol Metab"},{"key":"1807_CR92","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.2353\/ajpath.2010.100399","volume":"177","author":"HS Suh","year":"2010","unstructured":"Suh HS, Cosenza-Nashat M, Choi N et al (2010) Insulin-like growth factor 2 receptor is an IFN\u03b3-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders. Am J Pathol 177:2446\u20132458. https:\/\/doi.org\/10.2353\/ajpath.2010.100399","journal-title":"Am J Pathol"},{"key":"1807_CR93","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/ijms25073966","volume":"25","author":"J Szydlowska-Gladysz","year":"2024","unstructured":"Szydlowska-Gladysz J, Gorecka AE, Stepien J et al (2024) IGF-1 and IGF-2 as molecules linked to causes and consequences of obesity from fetal life to adulthood: A systematic review. Int J Mol Sci 25:3966. https:\/\/doi.org\/10.3390\/ijms25073966","journal-title":"Int J Mol Sci"},{"key":"1807_CR94","doi-asserted-by":"publisher","unstructured":"Uytterhoeven V, Verstreken P, Nachman E (2025) Synaptic sabotage: how Tau and \u03b1-Synuclein undermine synaptic health. J Cell Biol 224. https:\/\/doi.org\/10.1083\/jcb.202409104","DOI":"10.1083\/jcb.202409104"},{"key":"1807_CR95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2004.02.047","volume":"490","author":"PS Van Dam","year":"2004","unstructured":"Van Dam PS, Aleman A (2004) Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol 490:87\u201395. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.047","journal-title":"Eur J Pharmacol"},{"key":"1807_CR96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/JOE-12-0077","volume":"215","author":"M Walser","year":"2012","unstructured":"Walser M, Sam\u00e0 MT, Wickelgren R et al (2012) Local overexpression of GH and GH\/IGF1 effects in the adult mouse hippocampus. J Endocrinol 215:257\u2013268. https:\/\/doi.org\/10.1530\/JOE-12-0077","journal-title":"J Endocrinol"},{"key":"1807_CR97","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s10495-010-0547-z","volume":"15","author":"L Wang","year":"2010","unstructured":"Wang L, Yang HJ, Xia YY, Feng ZW (2010) Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT\/GSK-3\u03b2\/JNK signaling. Apoptosis 15:1470\u20131479. https:\/\/doi.org\/10.1007\/s10495-010-0547-z","journal-title":"Apoptosis"},{"key":"1807_CR98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fncel.2017.00014","volume":"11","author":"S Wrigley","year":"2017","unstructured":"Wrigley S, Arafa D, Tropea D (2017) Insulin-like growth factor 1: at the crossroads of brain development and aging. Front Cell Neurosci 11:14. https:\/\/doi.org\/10.3389\/fncel.2017.00014","journal-title":"Front Cell Neurosci"},{"key":"1807_CR99","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/molecules30030740","volume":"30","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wei J, Wang W et al (2025) Oleanolic acid slows down aging through IGF-1 affecting the PI3K\/AKT\/mTOR signaling pathway. Molecules 30:740. https:\/\/doi.org\/10.3390\/molecules30030740","journal-title":"Molecules"},{"key":"1807_CR100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L, Xie A (2018) The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3\u03b2 signaling in parkinson\u2019s disease dementia. Front Neurosci 12:73. https:\/\/doi.org\/10.3389\/fnins.2018.00073","journal-title":"Front Neurosci"},{"key":"1807_CR101","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12035-014-8717-6","volume":"51","author":"H Yuan","year":"2015","unstructured":"Yuan H, Chen R, Wu L et al (2015) The regulatory mechanism of neurogenesis by IGF-1 in adult mice. Mol Neurobiol 51:512\u2013522. https:\/\/doi.org\/10.1007\/s12035-014-8717-6","journal-title":"Mol Neurobiol"},{"key":"1807_CR102","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4103\/1673-5374.355815","volume":"18","author":"HY Zhang","year":"2023","unstructured":"Zhang HY, Jiang YC, Li JR et al (2023) Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of parkinson\u2019s disease. Neural Regen Res 18:1099\u20131106. https:\/\/doi.org\/10.4103\/1673-5374.355815","journal-title":"Neural Regen Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01807-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:32:06Z","timestamp":1772616726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01807-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01807-x","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}